Persistent residual inflammatory risk at 1 month after contemporary PCI: rationale for routine hsCRP reassessment and dual-target therapy.
Saved in:
| Title: | Persistent residual inflammatory risk at 1 month after contemporary PCI: rationale for routine hsCRP reassessment and dual-target therapy. |
|---|---|
| Authors: | Gong X; First Clinical Medical College, Yunnan University of Traditional Chinese Medicine, Kunming, China., Zhou C; Special Medical Department, Dazhou Central Hospital, Dazhou, China., Wu Y; First Clinical Medical College, Yunnan University of Traditional Chinese Medicine, Kunming, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 May 01; Vol. 17, pp. 1840386. Date of Electronic Publication: 2026 May 01 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1840386 |
